Improving Intravenous Drug Delivery Safety
ISMP has received and highlighted a variety of medication errors that have negatively impacted intravenous drug therapy safety. These events related to compounding and intravenous medication practices occur both within the pharmacy department as well as outside the pharmacy involving other practitioners. Although the healthcare industry has made advancements in their offerings of higher-level intravenous drug preparation and delivery devices, addressing the impact on quality, safety, workflow and staffing have resulted in slow adoption rates of these safer alternatives.
Join our faculty as they describe common unsafe practices and at-risk behaviors associated with intravenous drug therapy, review the pros and cons of different intravenous drug delivery systems, and share strategies for the mitigation of risk. Best practices as identified in ISMP Guidelines for Safe Practice of Adult IV Push Medications, ISMP Guidelines for Safe Preparation of Compounded Sterile Preparations and discussion of the Consensus Development Conference on the Safety of IV Drug Delivery Systems will be presented.
Following completion of this activity, participants will be able to:
- Identify the primary safety issues and at-risk behaviors associated with intravenous drug therapy.
- Discuss ISMP's Guidelines and the Consensus Development Conference on the Safety of IV Drug Delivery Systems.
- Compare and contrast perceptions and practices related to intravenous drug delivery over time.
- List the pros and cons of various intravenous drug delivery systems.
Upcoming Dates & Locations:
- California Society of Health-System Pharmacists Seminar 2019
Disneyland Hotel; Paradise Pier
Pacific Ballroom A
Friday, October 18, 2019; 6:30 AM - 7:45 AM (Registration now open!)
Speakers May Include:
Michael R. Cohen, RPh, MS, ScD (hon.), DPS (hon.), FASHP, President, ISMP
Christina Michalek, BS, RPh, FASHP, Medication Safety Specialist, ISMP and Administrative Coordinator, Medication Safety Officers Society
Christopher Fortier, PharmD, FASHP, Chief Pharmacy Officer, Massachusetts General Hospital
John Hertig, PharmD, MS, CPPS, Associate Professor, Butler University College of Pharmacy and Health Sciences
Michael Freudiger, PharmD, APh, BCPS, BCGP, Sterile Compounding Specialist & Consultant, Clinical Pharmacist
These activities are supported by Fresenius-Kabi.
This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.